RxSight, Inc. (RXST)
4.85
+0.05
(+1.04%)
USD |
NASDAQ |
Oct 08, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
RxSight Gross Profit Margin (Quarterly) : 76.72% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.72% |
| March 31, 2026 | 76.06% |
| December 31, 2025 | 77.47% |
| September 30, 2025 | 79.85% |
| June 30, 2025 | 74.89% |
| March 31, 2025 | 74.76% |
| December 31, 2024 | 71.59% |
| September 30, 2024 | 71.42% |
| June 30, 2024 | 69.51% |
| March 31, 2024 | 70.09% |
| December 31, 2023 | 61.77% |
| September 30, 2023 | 61.85% |
| Date | Value |
|---|---|
| June 30, 2023 | 57.74% |
| March 31, 2023 | 59.27% |
| December 31, 2022 | 46.13% |
| September 30, 2022 | 42.46% |
| June 30, 2022 | 42.15% |
| March 31, 2022 | 42.06% |
| December 31, 2021 | 34.05% |
| September 30, 2021 | 23.18% |
| June 30, 2021 | -16.72% |
| March 31, 2021 | 32.12% |
| June 30, 2020 | -18.00% |
| March 31, 2020 | 2.70% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 64.07% |
| Neogen Corp. | 47.35% |
| QuidelOrtho Corp. | 35.75% |
| Aspira Women's Health, Inc. | 55.28% |
| Biomerica, Inc. | -8.11% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -17.26% |
| Return on Assets | -14.78% |
| Return on Invested Capital | -16.58% |
| Profit Margin (Quarterly) | -35.85% |
| Operating Margin (Quarterly) | -40.81% |
| Return on Net Operating Assets | -60.06% |